Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.5, 2011-05, pp. : 605-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 653-681

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer

By Patel Sharmila Player Mark R

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1865-1882

Informa Healthcare

Access to resources Recommend Favorite

Targeting the IGF1 axis in cancer proliferation

By Bruchim Ilan Attias Zohar Werner Haim

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1179-1192

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2901-2913

Bentham Science Publishers

Access to resources Recommend Favorite

The IGF Axis in Prostate Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 719-727

Bentham Science Publishers

Access to resources Recommend Favorite